Fukui, Reiko
Watanabe, Takahiro
Morimoto, Koji
Fujimoto, Yukie
Nagahashi, Masayuki
Ishikawa, Eri
Hirota, Seiichi
Miyoshi, Yasuo http://orcid.org/0000-0001-8535-4008
Funding for this research was provided by:
Hyogo College of Medicine (no grant number was provided)
Article History
Received: 13 February 2023
Accepted: 17 April 2023
First Online: 28 April 2023
Declarations
:
: YM received research funding and honoraria from Chugai, AstraZeneca, Eli Lilly, Pfizer, MSD, Daiichi-Sankyo, Kyowa-Kirin, Taiho, and Esai. MN received research funding and honoraria from Chugai, AstraZeneca, Eli Lilly, Pfizer, Daiichi-Sankyo, Kyowa-Kirin, Taiho, Esai, Novartis, and Denka. The other authors declare that they have no conflicts of interest.
: This study was approved by the Ethics Committee of Hyogo College of Medicine (Nos. 106 and 1886) and conducted in accordance with the Declaration of Helsinki.
: Written informed consent was obtained from all patients whose samples were used for immunohistochemical staining. For the other patients, we retrospectively collected the clinical data and offered no risks to the participants. The Institutional Review Board waived the need for written informed consent.